Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury

Experimental Neurology

Volumn 254, Issue , 2014, Pages 121-133

  Bottai, Daniele ^a   Scesa, Giuseppe ^a   Cigognini, Daniela ^a,c   Adami, Raffaella ^a   Nicora, Emanuela ^a   Abrignani, Sergio ^b   Di Giulio, Anna Maria ^a   Gorio, Alfredo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Istituto Nazionale di Genetica Molecolare   (Italy)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Amniotic fluid cells; Angiogenesis; HGF; NG2; Spinal cord injury

Indexed keywords

AMNIOTIC FLUID CELLS; ANGIOGENESIS; HGF; NG2; SPINAL CORD INJURY;

AMNIOTIC FLUID; ANGIOGENIC PROTEINS; ANIMALS; ANTIGENS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LUNG; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PLURIPOTENT STEM CELLS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROTEOGLYCANS; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84893941876     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.01.015     Document Type: Article

References (46)

1. Bai L., Lennon D.P., Caplan A.I., DeChant A., Hecker J., Kranso J., Zaremba A., Miller R.H. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat. Neurosci. 2012, 15:862-870.
2. Ballermann M., Fouad K. Spontaneous locomotor recovery in spinal cord injured rats is accompanied by anatomical plasticity of reticulospinal fibers. Eur. J. Neurosci. 2006, 23:1988-1996.
3. Bartholdi D., Rubin B.P., Schwab M.E. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur. J. Neurosci. 1997, 9:2549-2560.
4. Basso D.M., Fisher L.C., Anderson A.J., Jakeman L.B., McTigue D.M., Popovich P.G. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 2006, 23:635-659.
5. Bottai D., Madaschi L., Di Giulio A.M., Gorio A. Viability-dependent promoting action of adult neural precursors in spinal cord injury. Mol. Med. 2008, 14:634-644.
6. Bottai D., Cigognini D., Madaschi L., Adami R., Nicora E., Menarini M., Di Giulio A.M., Gorio A. Embryonic stem cells promote motor recovery and affect inflammatory cell infiltration in spinal cord injured mice. Exp. Neurol. 2010, 223:452-463.
7. Bottai D., Cigognini D., Nicora E., Moro M., Grimoldi M.G., Adami R., Abrignani S., Marconi A.M., Di Giulio A.M., Gorio A. Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations. Restor. Neurol. Neurosci. 2012, 30:55-68.
8. Cananzi M., Atala A., De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod. Biomed. Online 2009, 18(Suppl. 1):17-27.
9. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.N., Traas J., Schugar R., Deasy B.M., Badylak S., Buhring H.J., Giacobino J.P., Lazzari L., Huard J., Peault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
10. De Coppi P., Bartsch G., Siddiqui M.M., Xu T., Santos C.C., Perin L., Mostoslavsky G., Serre A.C., Snyder E.Y., Yoo J.J., Furth M.E., Soker S., Atala A. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 2007, 25:100-106.
11. Detante O., Moisan A., Dimastromatteo J., Richard M.J., Riou L., Grillon E., Barbier E., Desruet M.D., De Fraipont F., Segebarth C., Jaillard A., Hommel M., Ghezzi C., Remy C. Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution. Cell Transplant. 2009, 18:1369-1379.
12. Dore-Duffy P., Cleary K. Morphology and properties of pericytes. Methods Mol. Biol. 2011, 686:49-68.
13. Farrington-Rock C., Crofts N.J., Doherty M.J., Ashton B.A., Griffin-Jones C., Canfield A.E. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004, 110:2226-2232.
14. Gorio A., Madaschi L., Zadra G., Marfia G., Cavalieri B., Bertini R., Di Giulio A.M. Reparixin, an inhibitor of CXCR2 function, attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord. J. Pharmacol. Exp. Ther. 2007, 322:973-981.
15. Gosden C.M. Amniotic fluid cell types and culture. Br. Med. Bull. 1983, 39:348-354.
16. Hall J. Midwifery basics: Blood tests for investigating maternal wellbeing. 1. Overview. Pract. Midwife 2010, 13:40-42.
17. Hashigasako A., Machide M., Nakamura T., Matsumoto K. Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J. Biol. Chem. 2004, 279:26445-26452.
18. Jeong S.R., Kwon M.J., Lee H.G., Joe E.H., Lee J.H., Kim S.S., Suh-Kim H., Kim B.G. Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury. Exp. Neurol. 2012, 233:312-322.
19. Kang S.G., Shinojima N., Hossain A., Gumin J., Yong R.L., Colman H., Marini F., Andreeff M., Lang F.F. Isolation and perivascular localization of mesenchymal stem cells from mouse brain. Neurosurgery 2010, 67:711-720.
20. Kitamura K., Fujiyoshi K., Yamane J., Toyota F., Hikishima K., Nomura T., Funakoshi H., Nakamura T., Aoki M., Toyama Y., Okano H., Nakamura M. Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury. PLoS One 2011, 6:e27706.
21. Li C., Zhou J., Shi G., Ma Y., Yang Y., Gu J., Yu H., Jin S., Wei Z., Chen F., Jin Y. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum. Mol. Genet. 2009, 18:4340-4349.
22. Liu Y., Wilkinson F.L., Kirton J.P., Jeziorska M., Iizasa H., Sai Y., Nakashima E., Heagerty A.M., Canfield A.E., Alexander M.Y. Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development. J. Pathol. 2007, 212:12-19.
23. Matsumoto K., Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem. 1996, 119:591-600.
24. Meirelles Lda S., Fontes A.M., Covas D.T., Caplan A.I. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009, 20:419-427.
25. Mori S., Matsui T., Kuze B., Asanome M., Nakajima K., Matsuyama K. Cerebellar-induced locomotion: reticulospinal control of spinal rhythm generating mechanism in cats. Ann. N. Y. Acad. Sci. 1998, 860:94-105.
26. Murphy S.V., Atala A. Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells. Semin. Reprod. Med. 2013, 31:62-68.
27. Nakamura T., Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc. Jpn. Acad. B Phys. Biol. Sci. 2010, 86:588-610.
28. Pan J.Z., Ni L., Sodhi A., Aguanno A., Young W., Hart R.P. Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion. J. Neurosci. Res. 2002, 68:315-322.
29. Park H.W., Lim M.J., Jung H., Lee S.P., Paik K.S., Chang M.S. Human mesenchymal stem cell-derived Schwann cell-like cells exhibit neurotrophic effects, via distinct growth factor production, in a model of spinal cord injury. Glia 2010, 58:1118-1132.
30. Puceat M., Ballis A. Embryonic stem cells: from bench to bedside. Clin. Pharmacol. Ther. 2007, 82:337-339.
31. Reier P.J. Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx 2004, 1:424-451.
32. Rosen A.B., Kelly D.J., Schuldt A.J., Lu J., Potapova I.A., Doronin S.V., Robichaud K.J., Robinson R.B., Rosen M.R., Brink P.R., Gaudette G.R., Cohen I.S. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007, 25:2128-2138.
33. Schrepfer S., Deuse T., Reichenspurner H., Fischbein M.P., Robbins R.C., Pelletier M.P. Stem cell transplantation: the lung barrier. Transplant. Proc. 2007, 39:573-576.
34. Schultz S.S. Adult stem cell application in spinal cord injury. Curr. Drug Targets 2005, 6:63-73.
35. Shimamura M., Sato N., Sata M., Wakayama K., Ogihara T., Morishita R. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats. Brain Res. 2007, 1151:188-194.
36. Siegel N., Rosner M., Hanneder M., Freilinger A., Hengstschlager M. Human amniotic fluid stem cells: a new perspective. Amino Acids 2008, 35:291-293.
37. Soleymaninejadian E., Pramanik K., Samadian E. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am. J. Reprod. Immunol. 2012, 67:1-8.
38. Stallcup W.B. The NG2 proteoglycan: past insights and future prospects. J. Neurocytol. 2002, 31:423-435.
39. Stallcup W.B., Huang F.J. A role for the NG2 proteoglycan in glioma progression. Cell Adhesion Migr. 2008, 2:192-201.
40. Stegmuller J., Schneider S., Hellwig A., Garwood J., Trotter J. AN2, the mouse homologue of NG2, is a surface antigen on glial precursor cells implicated in control of cell migration. J. Neurocytol. 2002, 31:497-505.
41. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008, 8:726-736.
42. Vitellaro-Zuccarello L., Mazzetti S., Madaschi L., Bosisio P., Gorio A., De Biasi S. Erythropoietin-mediated preservation of the white matter in rat spinal cord injury. Neuroscience 2007, 144:865-877.
43. Weibel E.R. Stereological Methods. Practical Methods for Biological Morphometry 1979, vol. I. Academic Press, New York.
44. Wilson B.S., Imai K., Natali P.G., Ferrone S. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int. J. Cancer 1981, 28:293-300.
45. Xiaowei H., Ninghui Z., Wei X., Yiping T., Linfeng X. The experimental study of hypoxia-inducible factor-1alpha and its target genes in spinal cord injury. Spinal Cord 2006, 44:35-43.
46. Yan J., Li Y., Qiu H., Lu G., Wu Z., Lin J., Zhang W. Immunohistochemical study of the presence of mast cells in idiopathic orbital inflammatory pseudotumor: possible role of mast cells in the course of its pathogenesis. Int. Ophthalmol. 2007, 27:235-239.